Notably, NOTCH1 expression was higher in benign tumors compared to precancerous and malignant tumors, whereas FGFR2 expression showed an opposite trend, with higher levels in precancerous and malignant tumors compared to benign tumors. This evidence concerns the gene NOTCH1 and cancer.